Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.

Coding mutation Copy number alteration Druggable gene Esophageal squamous cell carcinoma FAT1 FGFR1 LRP1B Mutational signature Structural variation Whole genome sequencing

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2020
Historique:
received: 07 10 2019
accepted: 14 05 2020
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 4 7 2020
Statut: epublish

Résumé

Esophageal squamous cell carcinoma (ESCC) is the predominant type of esophageal cancer in the Asian region, including Japan. A previous study reported mutational landscape of Japanese ESCCs by using exome sequencing. However, somatic structural alterations were yet to be explored. To provide a comprehensive mutational landscape, we performed whole genome sequencing (WGS) analysis of biopsy specimens from 20 ESCC patients in a Japanese population. WGS analysis identified non-silent coding mutations of

Identifiants

pubmed: 32617189
doi: 10.7717/peerj.9294
pii: 9294
pmc: PMC7323713
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e9294

Informations de copyright

©2020 Dutta et al.

Déclaration de conflit d'intérêts

Kenta Nakai is an Academic Editor for PeerJ.

Références

Nature. 2010 Oct 28;467(7319):1109-13
pubmed: 20981101
Genet Med. 2015 Jul;17(7):569-77
pubmed: 25356972
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Oral Oncol. 2016 Jan;52:75-84
pubmed: 26728105
Nat Genet. 2013 Mar;45(3):253-61
pubmed: 23354438
Sci Rep. 2017 Nov 10;7(1):15324
pubmed: 29127303
Nat Commun. 2017 May 26;8:15290
pubmed: 28548104
Sci Rep. 2015 Oct 27;5:14237
pubmed: 26503331
Cancer Invest. 2017 Jan 2;35(1):36-42
pubmed: 27901576
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Ann Oncol. 2016 Oct;27(10):1836-48
pubmed: 27436848
PeerJ. 2019 Feb 6;7:e6375
pubmed: 30755830
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
J Hum Genet. 2017 Aug;62(8):783-788
pubmed: 28381877
Genome Res. 2018 Nov;28(11):1747-1756
pubmed: 30341162
Oncotarget. 2017 Jun 27;8(26):41890-41902
pubmed: 28514750
Oncotarget. 2019 Jun 11;10(39):3835-3839
pubmed: 31231463
Cell. 2012 May 25;149(5):979-93
pubmed: 22608084
Int J Mol Sci. 2018 Dec 12;19(12):
pubmed: 30545040
J Clin Endocrinol Metab. 2015 Mar;100(3):E493-502
pubmed: 25490274
Gastroenterology. 2016 May;150(5):1171-1182
pubmed: 26873401
Ann Gastroenterol Surg. 2018 May 28;2(4):253-265
pubmed: 30003188
Am J Hum Genet. 2016 Feb 4;98(2):256-74
pubmed: 26833333
Oral Oncol. 2017 Oct;73:27-35
pubmed: 28939073
World J Gastrointest Oncol. 2014 May 15;6(5):121-8
pubmed: 24834142
Mutat Res. 2010 Feb;696(2):130-8
pubmed: 20083228
PLoS One. 2014 Aug 29;9(8):e105524
pubmed: 25171497
Nat Genet. 2016 Oct;48(10):1131-41
pubmed: 27595477
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073
pubmed: 29156001
Mol Cell. 2002 Nov;10(5):1247-53
pubmed: 12453430
Nat Genet. 2016 May;48(5):500-9
pubmed: 27064257
Am J Hum Genet. 2015 Apr 2;96(4):597-611
pubmed: 25839328
Science. 2016 Nov 4;354(6312):618-622
pubmed: 27811275
Ann Oncol. 2018 Apr 1;29(4):938-944
pubmed: 29351612
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nat Methods. 2013 Dec;10(12):1209-10
pubmed: 24122041
Nat Genet. 2020 Mar;52(3):331-341
pubmed: 32025003
Ann Oncol. 2017 Jan 1;28(1):83-89
pubmed: 28177435
Gut. 2012 May;61(5):673-84
pubmed: 22315472
Nat Genet. 2011 Jun 05;43(7):679-84
pubmed: 21642993
PLoS One. 2011;6(10):e26399
pubmed: 22065993
PLoS One. 2015 Nov 10;10(11):e0141867
pubmed: 26555375
J Craniomaxillofac Surg. 2014 Oct;42(7):1087-94
pubmed: 24556525
Int J Cancer. 2016 May 15;138(10):2322-33
pubmed: 26455580
Am Soc Clin Oncol Educ Book. 2018 May 23;38:249-261
pubmed: 30231398
Nat Genet. 2014 May;46(5):467-73
pubmed: 24686850
BMC Cancer. 2018 Aug 16;18(1):826
pubmed: 30115035
Nature. 2014 May 1;509(7498):91-5
pubmed: 24670651
Genes Chromosomes Cancer. 2019 May;58(5):324-338
pubmed: 30350478
Hum Mutat. 2014 Jun;35(6):702-14
pubmed: 24488880
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Am J Hum Genet. 2016 Apr 7;98(4):709-27
pubmed: 27058444
Mol Cell Biochem. 2017 Jul;431(1-2):75-85
pubmed: 28258440
Carcinogenesis. 2018 Dec 13;39(11):1320-1330
pubmed: 30102337
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
J Epidemiol. 2013;23(4):233-42
pubmed: 23629646
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6109-14
pubmed: 23536305
Cell. 2013 Mar 14;152(6):1226-36
pubmed: 23498933
PLoS One. 2012;7(6):e39797
pubmed: 22761904
Cell Rep. 2016 Jul 19;16(3):672-83
pubmed: 27373164
BMC Cancer. 2017 May 26;17(1):375
pubmed: 28549420
PLoS Genet. 2014 Jan 30;10(1):e1004139
pubmed: 24497845
Oral Oncol. 2013 Feb;49(2):144-51
pubmed: 22944049
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Oncogene. 2017 Apr 20;36(16):2243-2254
pubmed: 27819679

Auteurs

Munmee Dutta (M)

Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Chiba, Japan.
Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Hidewaki Nakagawa (H)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Hiroaki Kato (H)

Department of Surgery, Faculty of Medicine, Kindai University, Osaka, Japan.

Kazuhiro Maejima (K)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Shota Sasagawa (S)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Kaoru Nakano (K)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Aya Sasaki-Oku (A)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Akihiro Fujimoto (A)

Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Raúl Nicolás Mateos (RN)

Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Chiba, Japan.
Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Ashwini Patil (A)

Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Hiroko Tanaka (H)

Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Satoru Miyano (S)

Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Health Intelligence Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Takushi Yasuda (T)

Department of Surgery, Faculty of Medicine, Kindai University, Osaka, Japan.

Kenta Nakai (K)

Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Chiba, Japan.
Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Masashi Fujita (M)

Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Classifications MeSH